Rockbridge Investment Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-272
Closed -$5.35K 705
2022
Q1
$5.35K Hold
272
﹤0.01% 613
2021
Q4
$9K Buy
272
+50
+23% +$2.01K ﹤0.01% 585
2021
Q3
$9K Buy
+222
New +$8.05K ﹤0.01% 535

Other funds holding GDRX

Rockbridge Investment Management's GDRX Position: Q2 2022 in Review

Rockbridge Investment Management sold out of GoodRx Holdings (GDRX) in Q2 2022, closing a stake of 272 shares — an estimated $5.35K sold.

Rockbridge Investment Management first reported a position in GDRX in Q3 2021 and held it in 3 quarters. The position peaked at $9K in Q4 2021. 174 funds tracked by Wall St. Rank hold GDRX as of Q2 2022.

  • Rockbridge Investment Management reported no remaining GoodRx Holdings position as of Q2 2022 after selling out during the quarter.
  • Rockbridge Investment Management sold 272 GoodRx Holdings shares in Q2 2022, an estimated $5.35K.
  • Rockbridge Investment Management first reported a position in GoodRx Holdings in Q3 2021 and held it in 3 quarters.
  • Rockbridge Investment Management's GoodRx Holdings position peaked at $9K in Q4 2021.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2022.

Based on Rockbridge Investment Management's 13F filing for Q2 2022, filed 28 May 2024.